Interleukin‐8 (IL‐8), a CXC chemokine and also known as CXCL8, was initially described as an inflammatory innate immune response mediator and subsequently shown to be a potent angiogenic factor leading to tumour progression and metastasis in various human cancers.11 Here, CXCL8 is linked to cancer.